Evidence map›Paper›PMID 35548175›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2022

Aryan Rafiee Zadeh, Aynaz Foroughi Eghbal, Seyed Mahdi Mirghazanfari, Mohammad Reza Ghasemzadeh, Ehsan Nassireslami, Vahid Donyavi

Open access · goldAbstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Investigation of the Immunomodulatory and Neuroprotective Properties ofInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Chronic Treatment withInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Evaluation of sleep quality in faculty members of Isfahan university of medical sciences.International journal of physiology, pathophysiology and pharmacology · 2023
    Article
  14. Review
  15. Article
  16. Effect of self-efficacy-based training on metabolic control of patients with type 2 diabetes.International journal of physiology, pathophysiology and pharmacology · 2022
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Aryan Rafiee ZadehAJA University of Medical Sciences, Tehran, Iran.
Aynaz Foroughi EghbalSchool of Medicine, Urmia University of Medical Sciences, West Azarbaijan, Iran.
Seyed Mahdi MirghazanfariDepartment of Physiology and Iranian medicine, School of Medicine, AJA University of Medical science, Tehran, Iran.
Mohammad Reza GhasemzadehAssistant Professor of Psychiatry, School of Medicine, 505 Hospital, AJA University of Medical Sciences, Tehran, Iran.
Ehsan NassireslamiToxin Research Center, AJA University of Medical Sciences, Tehran, Iran.
Vahid DonyaviAssociate Professor of Psychiatry, AJA University of Medical Sciences, Tehran, Iran.
Aja University of Medical Sciences · IRIsfahan University of Medical Sciences · IRUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Here, we aimed to investigate the therapeutic effects of Materials and Methods: This clinical trial was performed in 2021 in the hospitals of military forces in Tehran on 52 male patients with major depressive disorder treated with sertraline. We used the Depression, Anxiety, and Stress Scale-21 Items (DASS-21) questionnaire to assess the patients. Serum BDNF levels were measured by the enzyme-linked immunosorbent assay. Patients were then divided into two groups receiving 1000 mg Results: After treatments, we observed significantly decreased DASS-21 score (-11.24 ± 5.69) in the intervention group ( Conclusion: The use of

Indexed as

Brain-derived neurotrophic factordepressive disorderNigella sativa

Identifiers

PMID35548175
PMCPMC9081508
OpenAlexW4226063093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.